It’s Not "Just Hives": Advancing Targeted Care in Chronic Spontaneous Urticaria
Please visit answersincme.com/860/2026-MC-001884-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Marc Serota, MD; Kristin Sokol, MD, MS, MPH; and Michelle Tarbox, MD. In this activity, experts in chronic spontaneous urticaria (CSU) discuss strategies to reduce diagnostic delays and how to personalize care beyond antihistamines. Upon completion of this activity, participants should be better able to: Recognize the impact of delayed diagnosis on disease control in patients with CSU; Review key inflammatory pathways—including type 2 inflammation—in CSU pathogenesis and how targeted therapies modulate them; Assess the latest clinical data for targeted therapies for the treatment of CSU; and Apply evidence-based strategies to personalize the management of antihistamine-refractory CSU.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from CME in Minutes: Education in Dermatology
From Surgery to Systemic Therapy: A Collaborative Discussion on CSCC Neoadjuvant and Adjuvant Immunotherapy
Transforming Outcomes for Patients With Chronic Spontaneous Urticaria: A New Era of Targeted Therapy
From Evidence to Action: Expert Dialogues on the Evolving Role of Immunotherapy in Basal Cell Carcinoma
From Symptoms to Stability: Emerging OX40/OX40L‐Targeted Therapies, Durable AD Control, and Enhanced Quality of Life
Get summaries like this every morning.
Free AI-powered recaps of CME in Minutes: Education in Dermatology and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.